Why is Medicamen Organ. falling/rising?

As of 22-Sep, Medicamen Organics Ltd's stock price is currently at 35.05, reflecting a decrease of 0.65, or 1.82%. The stock has underperformed its sector today by 0.74%. In terms of returns, over the past week, the stock has shown a positive movement of 3.09%, but it has significantly underperformed over the longer term, with a decline of 14.51% over the past month and a staggering 34.97% year-to-date. The stock is currently trading higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a rise in investor participation, with delivery volume increasing by 200% against the 5-day average, indicating a potential interest from investors despite the overall negative trend. Broader market context shows that while Medicamen Organics has had a positive return over the past week, it has not kept pace with the benchmark Sensex, which has only increased by 0.53% during the same period. The stock's year-to-date performance is particularly concerning, as it has declined by 34.97%, contrasting sharply with the Sensex's gain of 6.59%. This divergence suggests that while there may be some short-term interest, the overall sentiment towards Medicamen Organics remains negative, contributing to its recent price decline.